- Release Date: 30/06/23 09:36
- Summary: Neuren completes enrolment in Phelan-McDermid Phase 2 trial
- Price Sensitive: Yes
- Download Document 128.16KB
Ann: Neuren completes enrolment in Phelan-McDermid Phase 2 trial
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.43 |
Change
0.090(0.47%) |
Mkt cap ! $2.461B | |||
| Open | High | Low | Value | Volume |
| $19.60 | $19.65 | $19.00 | $3.606M | 186.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 49 | $19.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.43 | 25 | 2 |
View Market Depth
| Last trade - 12.02pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.46 |
Change
0.090 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| $19.58 | $19.62 | $19.00 | 73234 | ||
| Last updated 12.22pm 06/06/2024 ? | |||||
| NEU (ASX) Chart |